Optiscan launches InVue device for on the spot pathology results

Microscopic imaging technology company Optiscan Imaging has revealed an innovative new medical imaging device, InVue, which is designed to enable precision surgery through real-time digital pathology. Manufactured in Melbourne in partnership with industrial design firm Design + Industry, InVue is a significant milestone for the company, traditionally known for its confocal microscope devices. Optiscan CEO…

Optiscan and Mayo Clinic to develop breast cancer imaging

Optiscan Imaging has entered into a collaboration through a know-how agreement with Mayo Clinic in the US to develop a digital confocal laser endomicroscopic imaging system for use in robotic surgery. The collaboration combines Optiscan’s engineering expertise in digital endomicroscopic hardware and software development with Mayo Clinic’s know-how in robotic surgery and quality patient care,…

$51 million for CRC-P industry research collaborations

The federal government has committed $51 million to support collaboration between industry and researchers under Round 15 of the Cooperative Research Centres Projects (CRC-P). The 21 grants support industry-led projects with promising commercial potential that solve a wide range of community and economic challenges, from diagnosing life-threatening infections more quickly to innovative environmental recycling processes.…

Optiscan completes key milestone

Medical imaging technology manufacturer Optiscan Imaging has completed a key milestone in its development of telepathology utilising its imaging systems that visualise biological structures in their natural environment. The company has been working with Canada’s Prolucid Technologies developing a telepathology platform that enables pathologists to undertake virtual biopsy assessments. The project has now passed the…